Adam K. Simpson
Net Worth

Last updated:

What is Adam K. Simpson net worth?

The estimated net worth of Mr. Adam K. Simpson is at least $5,181,154 as of 1 Feb 2024. He has earned $3,675,184 from insider trading and has received compensation worth at least $1,505,970 in Icosavax, Inc..

What is the salary of Adam K. Simpson?

Mr. Adam K. Simpson salary is $501,990 per year as Pres, Chief Executive Officer & Director in Icosavax, Inc..

How old is Adam K. Simpson?

Mr. Adam K. Simpson is 50 years old, born in 1975.

What stocks does Adam K. Simpson currently own?

As insider, Mr. Adam K. Simpson owns shares in one company:

Company Title Shares Price per share Total value
Icosavax, Inc. (ICVX) Pres, Chief Executive Officer & Director 358,657 $0 $0

What does Icosavax, Inc. do?

Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-241, a vaccine candidate with hMPV target; and IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2 target indication and is under Phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in Seattle, Washington.

ICVX logo
ICVX
Icosavax, Inc.

Adam K. Simpson insider trading

Icosavax, Inc.

Mr. Adam K. Simpson has made 11 insider trades between 2022-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 102,574 units of ICVX stock on 21 Dec 2023. As of 1 Feb 2024 he still owns at least 358,657 units of ICVX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 15,000 $1.04 $15,600
Sale
Common Stock 15,000 $15.29 $229,380
Option
Stock Option (Right to Buy) 15,000 $1.04 $15,600
Option
Stock Option (Right to Buy) 93,227 $1.04 $96,956
Option
Common Stock 93,227 $1.04 $96,956
Option
Common Stock 4,789 $0.84 $4,023
Option
Stock Option (Right to Buy) 4,789 $0.84 $4,023
Sale
Common Stock 15,000 $15.67 $235,095
Option
Common Stock 15,000 $1.04 $15,600
Option
Stock Option (Right to Buy) 15,000 $1.04 $15,600
Option
Stock Option (Right to Buy) 23,343 $0.84 $19,608
Option
Common Stock 102,574 $1.04 $106,677
Sale
Common Stock 50,000 $15.44 $772,200
Option
Stock Option (Right to Buy) 40,000 $2.47 $98,800
Option
Stock Option (Right to Buy) 102,574 $1.04 $106,677
Option
Common Stock 23,343 $0.84 $19,608
Sale
Common Stock 40,000 $15.43 $617,080
Option
Common Stock 40,000 $2.47 $98,800
Sale
Common Stock 62,205 $15.46 $961,503
Option
Stock Option (Right to Buy) 3,000 $0.84 $2,520
Option
Common Stock 3,000 $0.84 $2,520
Sale
Common Stock 11,788 $8.86 $104,465
Option
Common Stock 10,677 $1.04 $11,104
Option
Stock Option (Right to Buy) 10,677 $1.04 $11,104
Sale
Common Stock 7,506 $10.69 $80,262
Option
Stock Option (Right to Buy) 2,395 $0.84 $2,012
Option
Stock Option (Right to Buy) 10,678 $1.04 $11,105
Option
Common Stock 10,678 $1.04 $11,105
Option
Common Stock 2,395 $0.84 $2,012
Option
Common Stock 14,369 $0.84 $12,070
Option
Stock Option (Right to Buy) 14,369 $0.84 $12,070
Sale
Common Stock 66,764 $8.96 $598,406
Sale
Common Stock 1,904 $6.7 $12,764
Sale
Common Stock 7,017 $6.64 $46,572
Sale
Common Stock 2,456 $7.11 $17,457
Option
Common Stock 7,185 $0.84 $6,035
Option
Stock Option (Right to Buy) 7,185 $0.84 $6,035
Option
Stock Option (Right to Buy) 4,789 $0.84 $4,023
Option
Common Stock 4,789 $0.84 $4,023
Option
Stock Option (Right to Buy) 73,929 $1.04 $76,886
Option
Common Stock 73,929 $1.04 $76,886
Option
Common Stock 16,764 $0.84 $14,082
Option
Stock Option (Right to Buy) 16,764 $0.84 $14,082

Icosavax key executives

Icosavax, Inc. executives and other stock owners filed with the SEC:

  • Mr. Adam K. Simpson (50) Pres, Chief Executive Officer & Director
  • Mr. Douglas A. Holtzman M.P.H., Ph.D. (61) Chief Scientific Officer & Sec.
  • Mr. Niranjan Kanesa-thasan M.D. (65) Chief Medical Officer
  • Ms. Cassia Cearley Ph.D. (43) Treasurer & Chief Bus. Officer